Ascend Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Ascend Capital’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-101,444	Closed	-$1.15M	–	215
2014 Q3	$1.15M	Buy	101,444 +41,444	+69%	+$473K	0.03%	170
2014 Q2	$725K	Sell	60,000 -37,400	-38%	-$442K	0.02%	162
2014 Q1	$1.14M	Buy	97,400 +289	+0.3%	+$4.89K	0.03%	175
2013 Q4	$1.72M	Sell	97,111 -146,888	-60%	-$2.47M	0.05%	167
2013 Q3	$3.51M	Buy	243,999 +145,137	+147%	+$2.22M	0.13%	156
2013 Q2	$1.49M	Buy	+98,862	New	+$1.3M	0.06%	157

Other funds holding MNTA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Ascend Capital's MNTA Position: Q4 2014 in Review

Ascend Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2014, closing a stake of 101,444 shares — an estimated $1.15M sold.

Ascend Capital first reported a position in MNTA in Q2 2013 and held it in 6 quarters. The position peaked at $3.51M in Q3 2013. 148 funds tracked by Wall St. Rank hold MNTA as of Q4 2014.

Ascend Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
Ascend Capital sold 101,444 Momenta Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.15M.
Ascend Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
Ascend Capital's Momenta Pharmaceuticals, Inc. position peaked at $3.51M in Q3 2013.
148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2014.

Based on Ascend Capital's 13F filing for Q4 2014, filed 13 Feb 2015.